Categories: US News

Did RFK JR. Is it better for women’s health than News News? We’re about to find out

[ad_1]

It looks bad when Robert F. Kennedy Jr. He’s ahead of you on science policy – women’s health, making things worse – but that’s exactly what’s happening to Gov. Gavin Newlom last week.

Ouch.

At the Cabinet meeting, Kennedy went on a six-minute grovel with Trump. That’s pretty standard for these weird meetings, but the secretary of health and human services specifically praised the president for ending “a 20-year war on women by eliminating hormone replacement therapy.”

As shocking as it may sound, Rfk Jr. it has a valid point.

A few days later, from the New York Times conference in the ‘New York Times conference’, Oscar

“But it’s okay,” he said of the story of killing Deserhause’s proposed self-care bill (AB 432), which he had previously passed and had strong bipartisan support in the Legislature.

“Because he’s not going to be governor forever, and the way he’s paying attention to women, he’s half-hearted, self-sacrificing dummies,” Berry said. “It just means.”

These two events show that the care of the period is complex and contradictory in the last few years, as women not only speak freely, but they want to take care of that, but basically, it is rejected or dismissed as unnecessary.

If you look a little deeper, this period that seems to be close to the period of insurance comes to the problem of insurance that, male or female, many companies should deny proper care?

To keep it simple, menopause is a stage that all women go through where their fertility ends, which means that 50% of the population is affected by it. It has some special and simple symptoms in life – most of them can be treated, but often it is not because many doctors are not trained in the care of menstruation (or perimenopause, which comes first), and it comes a lot.

The result is that so many women stumble into menopause they don’t understand what is happening to them, or that there are excellent, scientifically supported treatments to help.

A prime example of that “Black Box” warning has been on many hormone replacement drugs since the Millennium, when one large but flawed study found that the drugs could increase the risk of cancer or other diseases.

The black box warning is the worst food and drug warning that can be placed on the drug, and its inclusion in the concept of hormone replacement, or HRT, puts a huge burden on its use.

Twenty years of subsequent research has not only proven the flaws in that initial analysis, but has also shown significant benefits to HRT. It can protect against cognitive decline, reduce heart disease and reduce symptoms such as hot flashes, among many other benefits.

In early November, the FDA removed those warnings from most HRT drugs. The result will be greater access to more women as doctors lose their reluctance to prescribe, and women lose their fear of using them.

“Misconceptions surrounding the risk have plagued for decades, retreated from real scientific teaching and led to the development of opportunities for older women,” said the chairman of the structure of real life advice people, “to public awareness about change.

While the rodgers are right, insurance coverage and doctors know that it keeps the problems of women who want care – that’s what the Care Act of Honorable Mentions Stations does.

The bill would have required private insurance companies to cover FDA-approved treatments and paid doctors who take voluntary continuing education classes on menstrual topics. That last version was already watered down by previous proposals that would have reported coverage of additional treatment options (such as non-FDA approved combined hormones) and made menstruation training necessary for doctors.

But Newloom appeared to take issue with the part of the Bill that prohibited insurance companies from using “utilization management” in menstrual management – and this is where we come back to where we agree with Rfk Jr.

Control of use, or um, in fact when insurance companies get to decide what the patient needs and what they do not allow – reviews, reviews and denials, which often seem to be more than care.

Now artificial intelligence is getting into the business of usage control, meaning it’s not for a human to decide our treatment. A multibillion dollar industry, under the guise of maintaining affordable health care, often does so by denying care.

Which asseblollermember Rebecca Bauer-Kahan (D-Orinda), author of the California Bill, put in the prohibition against UM.

“The standard is ‘medically necessary'” when it comes to insurance coverage, Bauer-Kahan points out.

“When you talk about menopause, that’s a really nice word, right? I mean, I’ll survive in the short term without treatment,” she said. “Now what is ‘medically necessary’ is a very vague thing when it comes to menopausal care.”

In his Veto message, NewsOm said that the rejection of UMUM “would reduce the ability of health systems to carry out the activities shown to ensure proper care while reducing unnecessary costs.”

But the truth, and the problem, with menstrual care is that it is specific to each woman. Like birth control pills, a treatment that works for one woman can cause side effects for another. There is often a lot of trial and error in finding the right menstrual cycle, and women need to be able to have the freedom and flexibility to work with each other and their doctor. Without interruption.

In June, Kennedy called the previous approval of the health industry a problem, and announced shortly after he had received a pledge from many insurance companies to change many treatments and procedures.

If that change happens, it will certainly be bad – hopefully – but again, let’s wait and see. Those changes should begin in January.

Back in California, NewAbeM applauded again for doing something about the ban on menstruation in January, when he announced his budget proposal. In his Veto message, NewAbeM said he would go this route – to include it in his budget package – rather than work on a new bill in the general legislative session. This remains the plan, although no details are available.

Apparently, someone forgot to mention it in the berry.

The budget is becoming increasingly catch-all with legislation that the governor wants to be done with little fuss because the budget and its trailer bills always pass in some way, and it can be an easy way for him to control.

New Newlom has made it an important part of his policies, and his presidential campaign, to be behind women’s rights, especially reproductive care – and women’s equality is the cause of his wife, first partner Jennifer Siebel Newbel.

But the governor has also long been reluctant to pass legislation with deals attached (a period report would raise premiums as low as 50 cents. With federal cuts, rising premiums and a hotly contested health care crisis, his observations are not being ignored.

But again, this time, maybe confused. The only real opposition to the California Bill came from the insurance companies. Go Ficcebo.

Bauer-Kahan said she has been in contact with the governor’s office, but remains committed to pursuing legislation that limits the use of the administration.

“I’m glad to hear that we’re going to hopefully achieve this, but it needs to be found in a way that makes a difference by getting the difference in care for menopausal women,” she said.

October’s October by Newloom made a ripple. Because of Berry’s punch, his January proposal will not only be noticed, but scrutinized.

If he ends the restrictions on UM, He will need to answer the broader question that the act will increase – insurance companies should end the decisions of doctors and patients?

It would be a strange day if January saw Kennedy and the Department of Health and Human Services questioning and providing better health options for California women.

And stranger still if the New New New Licess in the welfare of women.

[ad_2]
kimdc171

Recent Posts

미국 강경 발언이 중동 위기에 미칠 5가지 핵심 긴장 요소는 무엇인가?

최근 미국의 강경 발언이 중동 긴장도를 크게 높이고 있다. 현지에서는 여러 해석이 엇갈리며 불안감이 확산되는…

17 hours ago

10가지 미국 정치·사회 이슈 검색 트렌드 급상승, 위기의 징후일까?

최근 미국 내 정치·사회 이슈에 대한 검색량이 급격히 늘어난 것으로 보인다. 이런 변화가 단순한 유행인지…

2 days ago

리가켐바이오·에이프릴바이오, 52주 신고가 경신 – 어디까지 오를까?

요약: 리가켐바이오와 에이프릴바이오가 연이어 52주 신고가를 경신했다. 양사 주가는 바이오 업황 개선 기대와 개발 성과…

3 days ago

올해 국내 제약·바이오 테마 강세, 투자 위기 속 상승세 지속될까?

최근 국내 제약·바이오 주가가 연일 강세를 보인다. 시장에서는 모멘텀 유지 여부를 두고 여러 해석도 나온다.…

4 days ago

AI 서울 2026 핵심 발표 전격 공개, 산업 혁신의 미래는 어디로?

요약: AI 서울 2026의 핵심 발표가 최근 공개됐다. 이 행사는 산업 전반에 혁신 파동을 일으킬…

5 days ago

2026 미국 정치 긴장: Tim Walz 발언 논란 확산 위기?

미국 미네소타 주지사 팀 월츠가 최근 소말리아 보육시설 예산 발언으로 논란을 일으켰다.이 발언은 공교육과 이민…

6 days ago